256 related articles for article (PubMed ID: 14694918)
1. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment.
Takahashi M; Ohara T; Yamanaka H; Shimada A; Nakaho T; Makoto Y
Palliat Med; 2003 Dec; 17(8):673-8. PubMed ID: 14694918
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
3. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
[TBL] [Abstract][Full Text] [Related]
4. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
5. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.
Klepstad P; Hilton P; Moen J; Kaasa S; Borchgrevink PC; Zahlsen K; Dale O
BMC Clin Pharmacol; 2004 Oct; 4():7. PubMed ID: 15461818
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
Wolff T; Samuelsson H; Hedner T
Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
[TBL] [Abstract][Full Text] [Related]
8. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
9. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
Wolff T; Samuelsson H; Hedner T
Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
[TBL] [Abstract][Full Text] [Related]
10. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
Klepstad P; Kaasa S; Borchgrevink PC
Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
[TBL] [Abstract][Full Text] [Related]
12. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
Du X; Skopp G; Aderjan R
Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
[TBL] [Abstract][Full Text] [Related]
13. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.
Sakurada T; Takada S; Eguchi H; Izumi K; Satoh N; Ueda S
Pharm World Sci; 2010 Dec; 32(6):737-43. PubMed ID: 20730493
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
Hunt A; Joel S; Dick G; Goldman A
J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
[TBL] [Abstract][Full Text] [Related]
16. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
Hasselström J; Säwe J
Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
18. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
20. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.
van Dongen RT; Crul BJ; Koopman-Kimenai PM; Vree TB
Br J Clin Pharmacol; 1994 Sep; 38(3):271-3. PubMed ID: 7826830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
